up home page bottom

French German version Spanish version Italian version

headermask image

header image

category archive listing Category Archives: Anti-Depressant Use

Antipsychotics — Increased Risk of Mortality In Elderly Patients Treated for Dementia-related psychosis

June 18, 2008 – 8:00 am
Posted by H. Sandra Chevalier-Batik

Information for Healthcare Professionals — Antipsychotics
FDA ALERT [6/16/2008]:  FDA is notifying healthcare professionals that both conventional and atypical antipsychotics are associated with an increased risk of mortality in elderly patients treated for dementia-related psychosis. 
In April 2005, FDA notified healthcare professionals that […]

By H. Sandra Chevalier-Batik | Also posted in Big Pharma Watch, Elder Care, FDA Press Release, Health Advisory | Comments (0)

BIG PHARMA — 2008 1st Quarter Results

April 29, 2008 – 11:29 am
Posted by H. Sandra Chevalier-Batik

Eli Lilly and Merck reported their first-quarter results on April 21st
At Eli Lilly, earnings are expected to be up 14% year over year, to 95¢ per share, thanks to the success of Zyprexa,  its antipsychotic drug, and Cymbalta,  its depression treatment.
Analysts are less bullish on Merck.  They are forecasting a 2¢ increase in earnings, to […]

By H. Sandra Chevalier-Batik | Also posted in Big Pharma Watch | Comments (0)

Coming of Age on Antidepressants

April 16, 2008 – 12:37 pm
Posted by H. Sandra Chevalier-Batik

Inconvenient Woman has covered the issue of increased suicide rates for preteens and teenagers in previous Blog entries.
FDA Requiring Suicide Studies in Drug Trials
“…After decades of inattention to the possible psychiatric side effects of experimental medicines, the Food and Drug Administration is now requiring drug makers to study closely whether patients become suicidal during […]

By H. Sandra Chevalier-Batik | Also posted in Big Pharma Watch, Teen Suicide | Comments (0)

FDA Approves Wyeth Antidepressant

March 7, 2008 – 1:02 pm
Posted by H. Sandra Chevalier-Batik

Read This FDA Press Release to the Partridge Family Theme Song, “Come on Get Happy”
“Trav’lin’ along, here’s a song that we’re singing
Come on get happy
A whole lotta lovin’ is what we’ll be bringing
We’ll make you happy
We’ll make you happy
Come on get happy!”
Wyeth Gets Important FDA for “New” Antidepressant
Faced with the looming loss of patent protection […]

By H. Sandra Chevalier-Batik | Also posted in Big Pharma Watch, Menopause, Woman’s Health | Comments (0)

FDA Requiring Suicide Studies in Drug Trials

January 26, 2008 – 12:22 pm
Posted by H. Sandra Chevalier-Batik

After decades of inattention to the possible psychiatric side effects of experimental medicines, the Food and Drug Administration is now requiring drug makers to study closely whether patients become suicidal during clinical trials.

The new rules represent one of the most profound changes of the past 16 years to regulations governing drug development. But […]

By H. Sandra Chevalier-Batik | Also posted in Big Pharma Watch, FDA Press Release, Teen Suicide | Comments (0)

FDA’s Label Rule Criticized As Youth Suicides Increase

September 8, 2007 – 9:52 am
Posted by H. Sandra Chevalier-Batik

Experts Suggest Link Between Warnings and Startling New Trend
Suicide rates for preteens and teenagers increased sharply when the Food and Drug Administration slapped a “black box” warning on anti-depressants and doctors started writing fewer prescriptions for young people, according to federal data released Thursday.
The FDA’s warning, publicly debated in 2003 and enacted in 2004, highlighted […]

By H. Sandra Chevalier-Batik | Also posted in Children's Health, FDA Black Box Warning | Comments (0)